clinical trial · NCT07784621
A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults
Huons Co., Ltd.·phase1·not yet recruiting·n = 30
HypertensionLosartan (COZZAR®)Pitavastatin plus Ezetemibe
brief summary
This study evaluates the pharmacokinetic drug-drug interactions of repeated co-administration of HUC2A-752-A and HUC2A-752-B compared to monotherapy of each agent in healthy adults
started
Oct 1, 2026
primary completion
Feb 1, 2027
completion
Feb 1, 2027
last updated
Aug 25, 2026
detailed description
This randomized, open-label, 2-arm, 2-period, multiple-dose, phase 1 clinical trial evaluates the safety, tolerability, and pharmacokinetics of HUC2A-752 following repeated oral administration of HUC2A-752-A and HUC2A-752-B in healthy adult volunteers.
official title
An Open-Label, Multiple-oral Dosing, Fixed-Sequence Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol